India is emerging as a leader in global healthcare and research, with Hyderabad at the forefront. Trade and Investment Queensland (TIQ), the Queensland Government’s business agency, led a high-profile 20-member delegation at BioAsia 2025, reinforcing India-Queensland collaboration in research and innovation. The delegation was honored by the presence of Her Excellency, Honourable Governor of Queensland Dr. Jeanette Young, and The Honourable Minister for Finance, Trade, Employment, and Training in Queensland, Ros Bates. As a Global Sponsor for BioAsia 2025, TIQ played a pivotal role in driving key discussions at Asia’s premier life sciences and biotech forum, organized annually by the Government of Telangana.
This strategic partnership underscores both regions’ commitment to fostering innovation and advancing global healthcare. Hyderabad’s robust IT and research capabilities have positioned it as a world-class hub, seamlessly connected to global innovation centers like Boston, Singapore, and Queensland.
Professor Alan Rowan, Director and Interim Pro Vice Chancellor (Research Infrastructure) at the Australian Institute for Bioengineering and Nanotechnology, University of Queensland (UQ), emphasized India’s potential to lead in scientific research, supported by its IT advancements.
“Hyderabad is rapidly evolving into a global center for healthcare infrastructure and research. The city’s growing integration with international hubs like Boston, Singapore, and Queensland further cements its role in biotechnology and medical research,” said Prof. Alan Rowan.
The delegation included key industry leaders and researchers:
- Prof. Trent Munro, Director, Biotechnology Innovation, UQ
- Dr. Romain Tropée, Head of Science and Technology, Southern RNA (SRNA)
- Prof. Evelin Tiralongo, Director, Clinical Trial Unit, Griffith University
- Chris Peck, Chief Executive Officer, SRNA
- Dr. Teck Jack TAN, Chief Medical Officer, TeleMedC Pty Ltd
- Prof. Prasad Yarlagadda, Dean, Engineering, UniSQ
- Shannon Willoughby, Executive Director, Strategic Partnerships Office, UQ
- Sarah Costanzo, Associate Director, Advanced Manufacturing and Deep Technologies, UQ
- Dr. Harpreet Johal-Meredith, Business Development Director, Resolian Bioanalytics Brisbane
- Thomas Lake, Senior VP, Vaccine Alliances & Commercialization, Vaxxas
- Michael Power, Global Director – Sales, HealthCare Logic
- Dr. Christopher Ogg, Founder, HealthCare Logic
- Brett Sellars, Hospital Engagement Lead, HealthCare Logic
- Priyanka Risikesan, Deputy Chief Technology Officer, HealthCare Logic
- Prof. Rajiv Khanna, Co-Director, Queensland Immunology Research Centre, QIMR
- Dr. Rajiv Tyagi, Head of Strategic Commercial Alliances, QIMR
- Anand Gautam, Founder, G2Ome Consulting Pty Ltd
The discussions at BioAsia 2025 focused on joint research, clinical trials, and tech-driven healthcare solutions. This collaboration is set to drive new investments and deeper scientific cooperation between India and Queensland.
Abhinav Bhatia, Senior Trade & Investment Commissioner – South Asia, Trade and Investment Queensland, stated, “BioAsia 2025 deepens Queensland’s engagement with India’s thriving life sciences and technology ecosystem. With India as the world’s pharmacy and Queensland as a research powerhouse, this partnership fosters breakthroughs for global healthcare.”
This engagement solidifies Hyderabad’s role as a global leader in science and healthcare, paving the way for transformative advancements in the sector.
About Trade & Investment Queensland (TIQ):
Trade and Investment Queensland is the Queensland Government’s global business agency, with 18 offices across 14 key markets, including South Asia. TIQ supports Queensland exporters and promotes investment opportunities in the region.
For more details, visit: www.tiq.qld.gov.au
 leads a high-profile delegation at BioAsia 2025, strengthening India-Queensland ties in healthcare){kind=link}